HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Three cases of IMP-type metallo-β-lactamase-producing Enterobacter cloacae bloodstream infection in Japan.

Abstract
We report three cases of IMP-type metallo-β-lactamase-producing Enterobacter cloacae bloodstream infection, which showed minimum inhibitory concentration values for imipenem with 2 μg/ml in all isolates. Although carbapenems were initiated empirically in all cases, two of three cases died. The Clinical and Laboratory Standards Institute lowered the breakpoints of carbapenems for Enterobacteriaceae in 2010. However, the previous breakpoints are still used in many clinical laboratories, which can result in failure to detect carbapenem-resistant Enterobacteriaceae. Therefore, lower breakpoints of carbapenems should be used in clinical settings, and alternative tests for detecting metallo-β-lactamase such as polymerase chain reaction and immunochromatographic assays may contribute to better detection of carbapenem-resistant isolates.
AuthorsYohei Hamada, Koji Watanabe, Tatsuya Tada, Tada Tatsuya, Kazuhisa Mezaki, Sosuke Takeuchi, Toshio Shimizu, Teruo Kirikae, Norio Ohmagari
JournalJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (J Infect Chemother) Vol. 19 Issue 5 Pg. 956-8 (Oct 2013) ISSN: 1437-7780 [Electronic] Netherlands
PMID23160627 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Bacterial Proteins
  • beta-Lactamases
Topics
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents (pharmacology, therapeutic use)
  • Bacteremia (drug therapy, microbiology)
  • Bacterial Proteins
  • Enterobacter cloacae (drug effects, enzymology, isolation & purification)
  • Enterobacteriaceae Infections (drug therapy, microbiology)
  • Humans
  • Japan
  • Male
  • Microbial Sensitivity Tests
  • beta-Lactam Resistance
  • beta-Lactamases (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: